Advarra Integrated Solutions enable the safe, ethical, compliant, and efficient development of life-changing therapies.
Phone: +1 585-272-1960
Total raised: $30M
Founded date: 1985
Investors 1
| Date | Name | Website |
| - | Mainsail P... | mainsailpa... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.01.2018 | - | $30M | Mainsail P... |
Mentions in press and media 5
| Date | Title | Description |
| 23.01.2018 | Term Sheet — Tuesday, January 23 | LPs WAKE UP Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop In a new feature, my colleague Michal Lev-Ram delves into the inner-workings of Aspect Ventures, a rare gender-balanced VC firm. “O... |
| 23.01.2018 | Clinical trials, management software maker Bio-Optronics draws $30M investment | Bio-Optronics — a producer of software and services focused on clinical research, automated scheduling, and patient safety — has announced $30 million in funding from growth equity firm Mainsail Partners. The new funding will be used to acc... |
| 22.01.2018 | Mainsail Partners Invests $30M in Bio-Optronics | Bio-Optronics today announced a $30 million investment from Mainsail Partners, a growth equity firm that invests in fast-growing bootstrapped technology companies. Mainsail will partner with the Chief Executive Officer, Dan Kerpelman, and t... |
| 22.01.2018 | Bio-Optronics Receives $30M Growth Investment | Bio-Optronics, a Rochester, NY-based provider of software to healthcare organizations, received a $30m investment from Mainsail Partners. Mainsail will partner with the Chief Executive Officer, Dan Kerpelman, and the existing management tea... |
| - | Startups taking new approaches to clinical trials have netted $1.6 billion from investors. Meet the top 10 upstarts trying to bring drug research into the 21st century. | A medical technician handles coronavirus tests at the microbiology laboratory of Naples. Salvatore Laporta/Kontrolab/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Coronavir... |